<--- Back to Details
First PageDocument Content
Immune system / Immunology / Neurological disorders / Treatment of multiple sclerosis / Diagnostic criteria for MS / Glatiramer acetate / Expanded Disability Status Scale / Clinical trial / Optic neuritis / Multiple sclerosis / Autoimmune diseases / Health
Date: 2002-02-01 12:19:02
Immune system
Immunology
Neurological disorders
Treatment of multiple sclerosis
Diagnostic criteria for MS
Glatiramer acetate
Expanded Disability Status Scale
Clinical trial
Optic neuritis
Multiple sclerosis
Autoimmune diseases
Health

Disease Modifying Therapies in Multiple Sclerosis Report of

Add to Reading List

Source URL: www.neurology.org

Download Document from Source Website

File Size: 198,57 KB

Share Document on Facebook

Similar Documents

20th NSW Stem Cell Network Workshop - in collaboration with MS Research Australia Stem Cells in Multiple Sclerosis and Neurological Disease

DocID: 1vbZP - View Document

Insights into Type 1 Diabetes and Multiple Sclerosis Pathogenesis from Common Genetic Associations Sandeep K. Singh 1, Aziz A. Chentoufi 2, Jacob L. McCauley 3, Mehmet Tevfik Dorak 4 1Florida

DocID: 1vaUi - View Document

Cigarette Smoking and Incidence of Multiple Sclerosis -- Heman et al): 69 -- Ame...Page 1 of 14 Oxford Journals • ContactUs ......

DocID: 1v0yh - View Document

MULTIPLE SCLEROSIS Clues to its cause URI LEIBOWITZ Department of Neurology, Hadassah University Hospital and Hebrew U+riversity-Hada.ssah Medical School,

DocID: 1uW5T - View Document

CNS Vital Signs Advancing Multiple Sclerosis Care Adding Value to Your Practice by Providing Solutions for Measuring,  Monitoring and Managing Neurocognitive and Behavioral Health… www.CNSVS.com

DocID: 1uFcb - View Document